Dian Diagnostics Group Co.,Ltd. (300244.SZ)
- Previous Close
14.76 - Open
14.90 - Bid 14.26 x --
- Ask 14.27 x --
- Day's Range
14.20 - 14.69 - 52 Week Range
8.90 - 21.75 - Volume
18,128,700 - Avg. Volume
30,885,316 - Market Cap (intraday)
8.906B - Beta (5Y Monthly) 0.66
- PE Ratio (TTM)
-- - EPS (TTM)
-0.65 - Earnings Date --
- Forward Dividend & Yield 0.71 (4.81%)
- Ex-Dividend Date Sep 20, 2024
- 1y Target Est
11.90
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment. In addition, the company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions; multi-omics platform services; DP-TOF nucleic acid mass spectrometry solutions; and forensic drug testing products. Further, it provides supply chain optimization, information management, cold chain logistics, intelligent warehousing, sample library management, scientific research services, etc., as well as solutions for laboratory quality. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.
www.dazd.cn8,773
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 300244.SZ
View MorePerformance Overview: 300244.SZ
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300244.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300244.SZ
View MoreValuation Measures
Market Cap
9.22B
Enterprise Value
10.92B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.78
Price/Book (mrq)
1.41
Enterprise Value/Revenue
0.94
Enterprise Value/EBITDA
186.85
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.46%
Return on Assets (ttm)
1.72%
Return on Equity (ttm)
-2.59%
Revenue (ttm)
11.59B
Net Income Avi to Common (ttm)
-401.45M
Diluted EPS (ttm)
-0.65
Balance Sheet and Cash Flow
Total Cash (mrq)
1.69B
Total Debt/Equity (mrq)
38.79%
Levered Free Cash Flow (ttm)
1.09B